Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Angelini Pharma will be responsible to develop, manufacture and commercialize OV101 for the potential treatment of Angelman syndrome.
read more
Cobra has successfully produced and supplied two further DNA plasmids for the production of CombiGene’s gene therapy drug candidate CG01.
read more
Sanofi and MD Anderson Cancer Center announced a five-year strategic collaboration to accelerate the development of investigational treatments, including targeted and immune-therapies.
read more
Cobra Biologics has successfully produced and supplied two further DNA plasmids for the production of CombiGene’s gene therapy drug candidate CG01, which is being developed for the treatment of drug-resistant focal epilepsy.
read more
The CCMI at the NUI Galway and Sexton Biotechnologies announced the approval by an EU Regulatory Authority of a protocol for the manufacture of allogeneic bone marrow MSCs to be given intravenously to high-risk corneal transplant recipients in the ...
read more
The FDA has been determining the safest and most appropriate time to resume prioritized domestic inspections of FDA-regulated facilities and other associated activities since we first announced postponement in March.
read more
AGC Biologics is partnering with clinical-stage biotech company Molecular Partners to develop a new class of custom-built protein therapeutics known as DARPin.
read more
Ovid and Angelini Pharma have announced an agreement in which Angelini will be responsible to develop, manufacture and commercialize OV101 (gaboxadol).
read more
Avacta has entered into a collaboration with Integumen to evaluate recently generated Affimer reagents that bind the SARS-COV-2 spike protein for the detection of the coronavirus in waste water, to provide a real-time alert system to warn of ...
read more
Headlands Research announced its acquisition of two large CNS-focused clinical research centers; JEM Research Institute and Toronto Memory Program.
read more
Signant Health has announced the appointment of Roger Smith as Chief Executive Officer.
read more
SGS has received approval from FAMHP and has initiated the first site to begin a new clinical trial of a potential treatment for patients with COVID-19 related respiratory failure.
read more
LGC has announced the acquisition of The Native Antigen Company (NAC), a supplier of infectious disease antigens and antibodies.
read more
Orchard Therapeutics and MolMed have extended their collaboration – initiated in April 2018 – for a period of five years through June 2025.
read more
INTERPHEX, American Pharmaceutical Review, and Pharmaceutical Outsourcing announced the winners of the 2020 INTERPHEX Exhibitor Awards.
read more